Serum vitamins, carotenoids, and angina pectoris: Findings from the National Health and Nutrition Examination Survey III

Annals of Epidemiology

Volumn 10, Issue 2, 2000, Pages 106-116

  Ford, Earl S ^a   Giles, Wayne H ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Angina pectoris; Ascorbic acid; Carotenoids; Folic acid; Vitamin A; Vitamin B 12; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENOID; CYANOCOBALAMIN; FOLIC ACID; RETINOL; VITAMIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; CAROTENOIDS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLIC ACID; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK; VITAMINS;

EID: 0033968122     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00038-1     Document Type: Article

References (60)

1. Thom T.J., Maurer J. Time trends for coronary heart disease mortality and morbidity. Higgins M.W., Luepker R.V. Trends in Coronary Heart Disease Mortality. The Influence of Medical Care. 1988;7-15 Oxford University Press, New York, NY.
2. Ness A.R., Powles J.W. Fruit and vegetables, and cardiovascular disease. A review Intl J Epidemiol. 26:1997;1-13.
3. Jha P., Flather M., Lonn E., Farkouh M., Yusuf S. The antioxidant vitamins and cardiovascular disease. Ann Int Med. 123:1995;860-872.
4. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 274:1995;1049-1057.
5. Simon J.A. Vitamin C and cardiovascular disease. A review J Am Coll Nutr. 11:1992;107-125.
6. Ness A.R., Powles J.W., Khaw K.T. Vitamin C and cardiovascular disease. A systematic review J Cardiovasc Risk. 3:1996;513-521.
7. Kok F.J., de Bruijn A.M., Vermeeren R., Hofman A., van Laar A., de Bruin M.et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality. A 9-year follow-up study in the Netherlands Am J Clin Nutr. 45:1987;462-468.
8. Labadarios D., Brink P.A., Weich H.F.H., Visser L., Louw M.E.J., Shephard G.S., van Stuijvenberg M.E. Plasma vitamin A, E, C and B6 levels in myocardial infarction. S Afr Med J. 71:1987;561-583.
9. Gey K.F., Moser U.K., Jordan P., Stähelin H.B., Eichholzer M., Lüdin E. Increased risk of cardiovascular disease at suboptimal concentrations of essential antioxidants. An epidemiological update with special attention to carotene and vitamin C Am J Clin Nutr. 57(suppl):1993;787S-797S.
10. Morris D.L., Kritchevsky S.B., Davis C.E. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA. 272:1994;1439-1441.
11. Street D.A., Comstock G.W., Salkeld R.M., Schuep W., Klag M.J. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction. Circulation. 90:1994;1154-1161.
12. Singh R.B., Ghosh S., Niaz M., Singh R., Beegum R., Chibo H.et al. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol. 76:1995;1233-1238.
13. Kohlmeier L., Kark J.D., Gomez-Gracia E., Martin B.C., Steck S.E., Kardinaal A.F.M.et al. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol. 146:1997;618-626.
14. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 330:1994;1029-1035.
15. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R.et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 334:1996;1145-1149.
16. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A.et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 334:1996;1150-1155.
17. Centers for Disease Control and Prevention. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat. Series 1; no. 32. Bethesda, MD: National Center for Health Statistics; 1994.
18. Gunter E.W., Lewis S.M., Koncikowski S.M. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. 1996;US Department of Health and Human Services/Public Health Service/Centers for Disease Control and Prevention, Atlanta, GA.
19. Assessment of Folate Methodology Used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). J Nutr. 125:1995;1371S-1398S.
20. Sowell A.L., Huff D.L., Yeager P.R., Caudill S.P., Gunter E.W. Retinol, α-tocopherol, lutein/zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, trans-β-carotene, and four retinyl esters in serum determined simultaneously by reversed phase HPLC with multiwavelength detection. Clin Chem. 40:1994;411-416.
21. Ford E.S., Will J.C., Bowman B.A., Narayan K. Diabetes mellitus and serum carotenoids. Findings from a national population-based survey Am J Epidemiol. 149;168-176:1999.
22. Shah B.V., Barnwell B.G., Bieler G.S. SUDAAN User's Manual, Version 7.5. 1997;Research Triangle Institute, Research Triangle Park, NC.
23. Gillilan R.E., Mondell B., Warbasse J.R. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J. 93:1977;444-449.
24. Salonen J.T., Salonen R., Penttilä I., Herranen J., Jauhiainen M., Kantola M.et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 56:1985;226-231.
25. Salonen J.T., Salonen R., Seppänen K., Kantola M., Parviainen M., Alfthan G.et al. Relationship between serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischemic heart disease in Eastern Finnish men. Atherosclerosis. 70:1988;155-160.
26. Riemersma R.A., Oliver M., Elton R.A., Alfthan G., Vartiainen E., Salo M.et al. Plasma antioxidants and coronary heart disease. Vitamins C and E, and selenium Eur J Clin Nutr. 44:1990;143-150.
27. Kardinaal A.F.M., Kok F.J., Ringstad J., Gomez-Aracena J., Mazaev V.P., Kohlmeier L.et al. Antioxidants in adipose tissue and risk of myocardial infarction. The EURAMIC Study Lancet. 342:1993;1379-1384.
28. Singh R.B., Niaz M.A., Sharma J.P., Kumar R., Bishnoi I., Begom R. Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Acta Cardiol. 49:1994;441-452.
29. Riemersma R.A., Wood D.A., MacIntyre C.C.A., Elton R.A., Gey K.F., Oliver M.F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 337:1991;1-5.
30. Torun M., Avci N., Yardim S. Serum levels of vitamin E in relation to cardiovascular diseases. J Clin Pharm Therap. 20:1995;335-340.
31. Enstrom J.E., Kanim L.E., Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 3:1992;194-202.
32. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1456.
33. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med. 328:1993;1444-1449.
34. Knekt P., Reunanen A., Järvinen R., Seppänen R., Heliövaara Aromaa A. Antioxidant vitamin intake and coronary mortality in longitudinal population study. Am J Epidemiol. 139:1994;1180-1189.
35. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 334:1996;1156-1162.
36. Losonczy K.G., Harris T.B., Havlik R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons. The Established Populations for Epidemiologic Studies of the Elderly Am J Clin Nutr. 64:1996;190-196.
37. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J.et al. Randomised controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant Study (CHAOS) Lancet. 347:1996;781-786.
38. DeMaio S.J., King S.B. III, Lembo N.J., Roubin G.S., Hearn J.A., Bhagavan H.N.et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr. 11:1992;68-73.
39. Hodis H.N., Mack W.J., Labree L., Cashinhemphill L., Sevanian A., Johnson R.et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 273:1995;1849-1854.
40. Enstrom J.E., Kanim L.E., Breslow L. The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California. Am J Public Health. 76:1986;1124-1130.
41. Rapola J.M., Virtamo J., Ripatti S., Huttunen J.K., Albanes D., Taylor P.R.et al. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 349:1997;1715-1720.
42. Bolton-Smith C., Woodward M., Tunstall-Pedoe H. The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr. 46:1992;85-93.
43. Serdula M.K., Byers T., Mokdad A.H., Simoes E., Mendlein J.M., Coates R.J. The association between fruit and vegetable intake and chronic disease risk factors. Epidemiology. 7:1996;161-165.
44. Gaziano J.M., Manson J.E., Branch L.G., Colditz G.A., Willett W.C., Buring J.E. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol. 5:1995;255-260.
45. Tardif J., Côté G., Lespérance J., Bourassa M., Lambert J., Doucet S.et al. for the Multivitamins and Probucol Study Group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 337:1997;365-372.
46. Princen H.M.G., van Poppel G., Vogelezang C., Buytenhek R., Kok F.J. Supplementation with vitamin E but not B-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb. 12:1992;554-562.
47. Feinleib M., Lambert P.M., Zeiner-Henriksen T., Rogot E., Hunt B.M., Ingster-Moore L. The British-Norwegian Migrant Study - analysis of parameters of mortality differentials associated with angina. Biometrics. 38(suppl):1982;55-71.
48. Reunanen A., Aromaa A., Pyorala K., Punsar S., Maatela J., Knekt P. The Social Insurance Institution's Coronary Heart Disease Study. Baseline data and 5-year mortality experience Acta Med Scand. 673(suppl):1983;1-120.
49. Rossouw J.E., Weich H.F.H., Steyn K., Kotze J.P., Kotze T.J. The prevalence of ischaemic heart disease in three rural South African communities. J Chron Dis. 37:1984;97-106.
50. Langford H.G., Oberman A., Borhani N.O., Entwisle G., Tung G. Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-up Program. Am Heart J. 108:1984;797-801.
51. Langford H.G. Further analyses of the Hypertension Detection and Follow-up Program. Drugs. 31(suppl 1):1986;23-28.
52. Wilcosky T., Harris R., Weissfeld L. The prevalence and correlates of Rose Questionnaire angina among women and men in the Lipid Research Clinics Program Prevalence study population. Am J Epidemiol. 125:1987;400-409.
53. Lacroix A.Z., Haynes S.G., Savage D.D., Itavlick R.J. Rose questionnaire angina among United States black, white and Mexican-American women and men. Am J Epidemiol. 129:1989;669-686.
54. Garber C.E., Carleton R.A., Heller G.V. Comparison of "Rose Questionnaire Angina" to exercise thallium scintigraphy. different findings in males and females J Clin Epidemiol. 45:1992;715-720.
55. Bass E.B., Follansbee W.P., Orchard T.J. Comparison of a supplemented Rose questionnaire to exercise thallium testing in men and women. J Clin Epidemiol. 42:1989;385-394.
56. Raczynski J.M., Taylor H., Cutter G., Hardin M., Rappaport N., Oberman A. Rose questionnaire responses among black and white inpatients admitted for coronary heart disease. Findings from the Birmingham-BHS Project Eth Dis. 3:1993;290-302.
57. Oberman A., Cutter G. Issues in the natural history and treatment of coronary heart disease in black populations. Surgical treatment Am Heart J. 108:1984;688-694.
58. Haywood L.J., Ell K., Sobel E., deGuzman M., Blumfield D. Rose questionnaire responses among black, Latino, and white subjects in two socioeconomic strata. Eth Dis. 3:1993;303-314.
59. Smith K.W., McGraw S.A., Crawford S.L., McKinlay J.B. Do blacks and whites differ in reporting Rose Questionnaire angina? Results of the Boston Health Care Project. Eth Dis. 3:1993;278-289.
60. Sorlie P.D., Cooper L., Schreiner P.J., Rosamond W., Szklo M. Repeatability and validity of the Rose Questionnaire for angina pectoris in the Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 49:1996;719-725.